Radiopharmaceuticals: From Molecular Imaging to Targeted Radionuclide Therapy
The research and development of smart radiodrugs is the goal of the Center of Radiopharmaceutical Science of ETH, PSI, and USZ. Positron Emission Tomography (PET) allows the non-invasive visualization of biochemical processes within the body. Radiolabeled PET-tracers allow the study of neu...
Main Authors: | P. August Schubiger, Jürgen Grünberg, Simon Mensah Ametamey, Michael Honer, Elisa Garcia-Garayoa, Peter Bläuenstein, Robert Waibel, Ilse Novak-Hofer, Roger Schibli |
---|---|
Format: | Article |
Language: | deu |
Published: |
Swiss Chemical Society
2004-10-01
|
Series: | CHIMIA |
Subjects: | |
Online Access: | https://chimia.ch/chimia/article/view/3897 |
Similar Items
-
Development of a methodology for the analysis of radionuclide impurities in radiopharmaceuticals by gamma-ray spectrometry
by: Eduardo Bonfim De Paula, et al.
Published: (2017-11-01) -
Editorial: Reviews in: Radiopharmaceuticals in nuclear medicine
by: Chuen-Yen Lau, et al.
Published: (2023-03-01) -
Targeted Radionuclide Therapy
by: David Cheng, et al.
Published: (2011-10-01) -
Treatment with Radiopharmaceuticals and Radionuclides in Breast Cancer: Current Options
by: Burcu Altıparmak Güleç, et al.
Published: (2021-07-01) -
Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
by: George Crișan, et al.
Published: (2022-04-01)